Trial Outcomes & Findings for Mobility Optimization Through Velocity Exercise (NCT NCT00844558)
NCT ID: NCT00844558
Last Updated: 2016-06-06
Results Overview
This is a questionnaire that evaluates self-reported difficulty in a person's ability to do discrete actions or activities primarily involving standing, stooping and fundamental walking activities without the help of others. Factors that may influence difficulty in task performance include pain, fatigue, fear, weakness, soreness, ailments, health conditions and disabilities. Scored from 14 to 70 with scores approaching 70 signifying high levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance), and scores approaching 14 signifying low levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance).
COMPLETED
NA
58 participants
0,3,6, and 12 months
2016-06-06
Participant Flow
Participant milestones
| Measure |
Gait
Gait Training Arm
Gait Training: Gait training with a physical therapist 2/week for the first 3 months followed by 1/week for the following 3 months
|
Control
Control Group
Control: There is no intervention associated with this arm of the study
|
|---|---|---|
|
Overall Study
STARTED
|
36
|
22
|
|
Overall Study
Received Allocated Intervention
|
33
|
21
|
|
Overall Study
3 Month Visit
|
29
|
19
|
|
Overall Study
6 Month Visit
|
28
|
18
|
|
Overall Study
12 Month Visit
|
24
|
18
|
|
Overall Study
COMPLETED
|
24
|
18
|
|
Overall Study
NOT COMPLETED
|
12
|
4
|
Reasons for withdrawal
| Measure |
Gait
Gait Training Arm
Gait Training: Gait training with a physical therapist 2/week for the first 3 months followed by 1/week for the following 3 months
|
Control
Control Group
Control: There is no intervention associated with this arm of the study
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
9
|
2
|
|
Overall Study
Death
|
1
|
0
|
|
Overall Study
Protocol Violation
|
1
|
1
|
|
Overall Study
Lost to Follow-up
|
0
|
1
|
|
Overall Study
Physician Decision
|
1
|
0
|
Baseline Characteristics
Mobility Optimization Through Velocity Exercise
Baseline characteristics by cohort
| Measure |
Gait
n=36 Participants
The gait participants were randomized and attended 24 biweekly 45-minute sessions directed by a physical therapist, which were composed of guided strategies to optimize knee movements during treadmill walking, using computerized motion analysis with visual biofeedback.
|
Control
n=22 Participants
The control participants received their usual care for symptomatic knee osteoarthritis (OA) through their usual healthcare providers and were not asked to make changes to their lifestyle.Usual care for these subjects may have included a yearly visit with their physician, use of pain medications for knee symptoms, knee surgery, and/or physical therapy.
|
Total
n=58 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
69.1 years
STANDARD_DEVIATION 7.3 • n=5 Participants
|
69.6 years
STANDARD_DEVIATION 6.4 • n=7 Participants
|
69.3 years
STANDARD_DEVIATION 7.35 • n=5 Participants
|
|
Sex: Female, Male
Female
|
22 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
32 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
14 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
36 participants
n=5 Participants
|
22 participants
n=7 Participants
|
58 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 0,3,6, and 12 monthsThis is a questionnaire that evaluates self-reported difficulty in a person's ability to do discrete actions or activities primarily involving standing, stooping and fundamental walking activities without the help of others. Factors that may influence difficulty in task performance include pain, fatigue, fear, weakness, soreness, ailments, health conditions and disabilities. Scored from 14 to 70 with scores approaching 70 signifying high levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance), and scores approaching 14 signifying low levels in ability to perform activities primarily involving standing, stooping, and fundamental walking (without assistance).
Outcome measures
| Measure |
Gait
n=29 Participants
No adverse events
|
Control Group
n=19 Participants
No adverse events
|
|---|---|---|
|
Change in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability Instrument
Change from baseline to month 3
|
3.3 units on a scale
Interval 1.1 to 5.5
|
-1.0 units on a scale
Interval -3.7 to 1.7
|
|
Change in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability Instrument
Change from baseline to month 6
|
3.1 units on a scale
Interval 0.5 to 5.7
|
0.8 units on a scale
Interval -2.3 to 4.0
|
|
Change in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability Instrument
Change from baseline to month 12
|
3.9 units on a scale
Interval -1.3 to 9.1
|
2.9 units on a scale
Interval -3.7 to 9.5
|
SECONDARY outcome
Timeframe: 0,3,6 and 12 monthsThis is a 42-item self-administered questionnaire that covers five patient-relevant dimensions, including pain and knee-related symptoms. This instrument has been found to be a reliable and responsive measure in older adults with knee OA as well as sensitive to changes in pain and knee-related symptoms over 6- and 12-mo periods. Scored from 0 to 100 with 100 indicating no pain.
Outcome measures
| Measure |
Gait
n=29 Participants
No adverse events
|
Control Group
n=19 Participants
No adverse events
|
|---|---|---|
|
Change in Knee Osteoarthritis Injury and Outcome Scale (KOOS) Pain
Change from baseline to month 3
|
8.2 units on a scale
Interval 2.8 to 13.5
|
1.1 units on a scale
Interval -5.5 to 7.7
|
|
Change in Knee Osteoarthritis Injury and Outcome Scale (KOOS) Pain
Change from baseline to month 6
|
5.4 units on a scale
Interval 0.1 to 10.7
|
1.7 units on a scale
Interval -4.8 to 8.2
|
|
Change in Knee Osteoarthritis Injury and Outcome Scale (KOOS) Pain
Change from baseline to month 12
|
10.1 units on a scale
Interval 4.4 to 15.8
|
2.8 units on a scale
Interval -4.4 to 10.1
|
SECONDARY outcome
Timeframe: 0,3,6 and 12 monthsThis instrument has been found to be a reliable and responsive measure in older adults with knee OA as well as sensitive to changes in pain and knee-related symptoms over 6- and 12-mo periods. Scored from 0 to 100 with 100 indicating no symptoms.
Outcome measures
| Measure |
Gait
n=29 Participants
No adverse events
|
Control Group
n=19 Participants
No adverse events
|
|---|---|---|
|
Change in KOOS Symptoms
Change from baseline to month 3
|
11.5 units on a scale
Interval 6.3 to 16.7
|
3.0 units on a scale
Interval -3.4 to 9.4
|
|
Change in KOOS Symptoms
Change from baseline to month 6
|
8.1 units on a scale
Interval 2.3 to 13.8
|
1.8 units on a scale
Interval -5.3 to 8.9
|
|
Change in KOOS Symptoms
Change from baseline to month 12
|
8.5 units on a scale
Interval 0.9 to 16.0
|
2.4 units on a scale
Interval -7.1 to 12.0
|
SECONDARY outcome
Timeframe: 0,3,6 and 12 monthsThe LDCW included both 2-min walk distance and 400-m walk time. This measure has been shown to be predictive of changes in community mobility. Per the LDCW protocol, for participants unable to walk 400 m, gait speed was estimated from the 2-min walk distance, so that all participant data were on the same scale.
Outcome measures
| Measure |
Gait
n=29 Participants
No adverse events
|
Control Group
n=19 Participants
No adverse events
|
|---|---|---|
|
Change in Long Distance Corridor Walk (LDCW) Time, Secs
Change from baseline to month 3
|
11.5 seconds
Interval 6.3 to 16.7
|
3.0 seconds
Interval -3.4 to 9.4
|
|
Change in Long Distance Corridor Walk (LDCW) Time, Secs
Change from baseline to month 6
|
8.1 seconds
Interval 2.3 to 13.8
|
1.8 seconds
Interval -5.3 to 8.9
|
|
Change in Long Distance Corridor Walk (LDCW) Time, Secs
Change from baseline to month 12
|
8.5 seconds
Interval 0.9 to 16.0
|
2.4 seconds
Interval -7.1 to 12.0
|
SECONDARY outcome
Timeframe: 0,3,6, and 12 monthsFunctional limitations specific to ascending stairs were assessed with a times stair climb, using a standard eight-stair flight (stair height = 19 cm)
Outcome measures
| Measure |
Gait
n=29 Participants
No adverse events
|
Control Group
n=19 Participants
No adverse events
|
|---|---|---|
|
Change in Stair Climb Time, Secs
Change from baseline to month 3
|
0.2 seconds
Interval -0.5 to 0.9
|
0.0 seconds
Interval -0.9 to 0.8
|
|
Change in Stair Climb Time, Secs
Change from baseline to month 6
|
-0.2 seconds
Interval -1.3 to 1.0
|
-1.4 seconds
Interval -2.9 to 0.0
|
|
Change in Stair Climb Time, Secs
Change from baseline to month 12
|
-0.3 seconds
Interval -1.3 to 0.7
|
-1.1 seconds
Interval -2.4 to 0.1
|
SECONDARY outcome
Timeframe: 0,3,6,and 12 monthsMeasured as the total time (in seconds) required to stand five times from a seated position in a standardized chair without using arms.
Outcome measures
| Measure |
Gait
n=29 Participants
No adverse events
|
Control Group
n=19 Participants
No adverse events
|
|---|---|---|
|
Change in Chair Stand Time
Change from baseline to month 3
|
-0.9 seconds
Interval -2.2 to 0.4
|
-1.0 seconds
Interval -2.8 to 0.8
|
|
Change in Chair Stand Time
Change from baseline to month 6
|
-1.9 seconds
Interval -3.5 to -0.3
|
-3.0 seconds
Interval -5.0 to -0.9
|
|
Change in Chair Stand Time
Change from baseline to month 12
|
-2.5 seconds
Interval -3.7 to -1.3
|
-2.9 seconds
Interval -4.5 to -1.3
|
Adverse Events
Gait
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place